Author Weber, Martin S.
-
2016 | Review
B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence
Kinzel, S.& Weber, M. S. (2016)
CNS Drugs, 30(12) pp. 1137-1148.
Adis Int Ltd. DOI: https://doi.org/10.1007/s40263-016-0396-6
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model
Romanelli, E.; Merkler, D.; Mezydlo, A.; Weil, M.-T.; Weber, M. S.; Nikic, I. & Potz, S. et al. (2016)
Nature Communications, 7 art. 13275. DOI: https://doi.org/10.1038/ncomms13275
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen
Kinzel, S.; Lehmann-Horn, K.; Torke, S.; Haeusler, D.; Winkler, A.; Stadelmann, C. & Payne, N. L. et al. (2016)
Acta Neuropathologica, 132(1) pp. 43-58. DOI: https://doi.org/10.1007/s00401-016-1559-8
Details DOI PMID PMC WoS
-
2017 | Journal Article | Letter Note
Biomarkers in radiologically isolated syndrome: The missing piece in the puzzle of treatment indication?
Fereidan-Esfahani, M.; Mahmudi, F.; Jahansouz, M.; Weber, M. S. & Rodriguez, M. (2017)
Journal of the Neurological Sciences, 375. DOI: https://doi.org/10.1016/j.jns.2017.01.055
Details DOI PMID PMC WoS
-
2017 | Review |
Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
Abdelhak, A.; Weber, M. S.& Tumani, H. (2017)
Frontiers in Neurology, 8.
Frontiers Media S.A.. DOI: https://doi.org/10.3389/fneur.2017.00234
Details DOI PMID PMC WoS
-
2017 | Journal Article | Research Paper |
Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.
Lehmann-Horn, K.; Kinzel, S. & Weber, M. S. (2017)
International journal of molecular sciences, 18(10) art. 2048. DOI: https://doi.org/10.3390/ijms18102048
Details DOI PMID PMC
-
2018 | Journal Article
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
Häusler, D.; Häusser-Kinzel, S.; Feldmann, L.; Torke, S.; Lepennetier, G.; Bernard, C. C. A. & Zamvil, S. S. et al. (2018)
Proceedings of the National Academy of Sciences, 115(39) pp. 9773-9778. DOI: https://doi.org/10.1073/pnas.1810470115
Details DOI
-
2018 | Journal Article
Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Central Nervous System Demyelination—A Novel Disease Entity?
Weber, M. S.; Derfuss, T. & Brück, W. (2018)
JAMA Neurology, 75(8) pp. 909. DOI: https://doi.org/10.1001/jamaneurol.2018.1055
Details DOI
-
2019 | Journal Article |
Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients
Traub, J. W.; Pellkofer, H. L.; Grondey, K.; Seeger, I.; Rowold, C.; Brück, W. & Husseini, L. et al. (2019)
Journal of Neuroinflammation, 16(1). DOI: https://doi.org/10.1186/s12974-019-1593-2
Details DOI
-
2019 | Journal Article
Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment options
Giotaki, I.; Lange, P. & Weber, M. S. (2019)
Expert Review of Neurotherapeutics, 19(3) pp. 277-283. DOI: https://doi.org/10.1080/14737175.2019.1583557
Details DOI
-
2019 | Journal Article
Immunological Aspects of Approved MS Therapeutics
Rommer, P. S.; Milo, R.; Han, M. H.; Satyanarayan, S.; Sellner, J.; Hauer, L. & Illes, Z. et al. (2019)
Frontiers in Immunology, 10 art. 1564. DOI: https://doi.org/10.3389/fimmu.2019.01564
Details DOI
-
2019 | Journal Article
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
Montalban, X.; Arnold, D. L.; Weber, M. S.; Staikov, I.; Piasecka-Stryczynska, K.; Willmer, J. & Martin, E. C. et al. (2019)
New England Journal of Medicine, 380(25) pp. 2406-2417. DOI: https://doi.org/10.1056/NEJMoa1901981
Details DOI
-
2019 | Journal Article |
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
Häusser-Kinzel, S. & Weber, M. S. (2019)
Frontiers in Immunology, 10 art. 201. DOI: https://doi.org/10.3389/fimmu.2019.00201
Details DOI PMID PMC
-
2019 | Journal Article |
Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis
Traub, J.; Traffehn, S.; Ochs, J.; Häusser‐Kinzel, S.; Stephan, S.; Scannevin, R. & Brück, W. et al. (2019)
Brain Pathology, 29(5) pp. 640-657. DOI: https://doi.org/10.1111/bpa.12711
Details DOI PMID PMC
-
2019 | Journal Article | Research Paper |
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough
Häusler, D. & Weber, M. S. (2019)
International Journal of Molecular Sciences, 20(1) art. 218. DOI: https://doi.org/10.3390/ijms20010218
Details DOI PMID PMC
-
2021 | Journal Article | Research Paper |
Proinflammatory CD20 + T Cells are Differentially Affected by Multiple Sclerosis Therapeutics
Quendt, C.; Ochs, J.; Häusser‐Kinzel, S.; Häusler, D. & Weber, M. S. (2021)
Annals of Neurology, 90(5) pp. 834-839. DOI: https://doi.org/10.1002/ana.26216
Details DOI
-
2021 | Journal Article | Research Paper |
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?
Geladaris, A.; Häusler, D. & Weber, M. S. (2021)
International Journal of Molecular Sciences, 22(7) pp. 3461. DOI: https://doi.org/10.3390/ijms22073461
Details DOI
-
2021 | Journal Article |
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Frisch, E. S.; Pretzsch, R. & Weber, M. S. (2021)
Neurotherapeutics, 18(3) pp. 1602-1622. DOI: https://doi.org/10.1007/s13311-021-01048-z
Details DOI
-
2022 | Journal Article
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study
Weber, M. S.; Buttmann, M.; Meuth, S. G.; Dirks, P.; Muros-Le Rouzic, E.; Eggebrecht, J. C. & Hieke-Schulz, S. et al. (2022)
Frontiers in Neurology, 13 art. 863105. DOI: https://doi.org/10.3389/fneur.2022.863105
Details DOI